Outcomes Following Hematopoietic Stem Cell Transplantation in Patients Treated With Chemotherapy With or Without Gemtuzumab Ozogamicin for Acute Myeloid Leukemia

被引：0

作者：

Lambert, J. ^{[1
]}

Raffoux, E. ^{[2
]}

Chantepie, S. ^{[3
]}

Gastaud, L. ^{[4
]}

Legrand, O. ^{[5
]}

Marolleau, J. -P. ^{[6
]}

Pautas, C. ^{[7
]}

de Latour, R. Peffault ^{[8
]}

Thomas, X. ^{[9
]}

Turlure, P. ^{[10
]}

Benner, R. J. ^{[11
]}

Vandendries, E. ^{[12
]}

Gogat, K. ^{[13
]}

Dombret, H. ^{[2
]}

Castaigne, S. ^{[1
]}

机构：

[1] Ctr Hosp Versailles, Serv Hematol & Oncol, Le Chesnay, France

[2] Univ Paris Diderot, Hop St Louis, AP HP, Paris, France

[3] CHU Normandie Caen, Serv Hematol, Caen, France

[4] Ctr Lacassagne, Serv Hematol, Nice, France

[5] Univ Paris Pierre & Marie, Hop St Antoine, AP HP, Paris, France

[6] CHU Amiens, Serv Hematol, Amiens, France

[7] Hop Henri Mondor, Serv Hematol & Therapie Cellulaire, Creteil, France

[8] Hop St Louis, Hematol Greffe, Paris, France

[9] Ctr Hosp Lyon Sud, Serv Hematol, Lyon, France

[10] CHU Limoges, Serv Hematol & Therapie Cellulaire, Limoges, France

[11] Pfizer Inc, Global Prod Dev, Groton, CT 06340 USA

[12] Pfizer Inc, Cambridge, MA USA

[13] Pfizer Inc, Global Clin Dev, Paris, France

来源：

关键词：

acute myeloid leukemia; gemtuzumab ozogamicin; stem cell transplantation;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BSH19-PO-0

引用

页码：36 / 37

页数：2